These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23255086)

  • 1. Extrafoveal changes following intravitreal bevacizumab injections for macular edema secondary to branch retinal vein occlusion: an mfERG and OCT study.
    Park S; Cho IH; Park TK; Nam WH; Ohn YH
    Doc Ophthalmol; 2013 Apr; 126(2):137-48. PubMed ID: 23255086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.
    Loukianou E; Brouzas D; Chatzistefanou K; Koutsandrea C
    Int Ophthalmol; 2016 Feb; 36(1):21-36. PubMed ID: 25820576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Potential Ischemic Effect of Intravitreal Bevacizumab on Unaffected Retina in Treatment-Naïve Macular Edema Due to Branch Retinal Vein Occlusion: A Prospective, Interventional Case-Series.
    Rishi P; Raka N; Rishi E
    PLoS One; 2016; 11(9):e0162533. PubMed ID: 27618696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological and structural assessment of the central retina following intravitreal injection of bevacizumab for treatment of macular edema.
    Shetty R; Pai SA; Vincent A; Shetty N; Narayana KM; Sinha B; Shetty BK
    Doc Ophthalmol; 2008 Mar; 116(2):129-35. PubMed ID: 17960440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
    Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
    Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
    Jaissle GB; Szurman P; Feltgen N; Spitzer B; Pielen A; Rehak M; Spital G; Heimann H; Meyer CH;
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):183-92. PubMed ID: 21337042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of macular edema due to branch retinal vein occlusion with single or multiple intravitreal injections of bevacizumab.
    Yunoki T; Miyakoshi A; Nakamura T; Fujita K; Fuchizawa C; Hayashi A
    Jpn J Ophthalmol; 2012 Mar; 56(2):159-64. PubMed ID: 22246387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.
    Kim M; Jeong S; Sagong M
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):691-697. PubMed ID: 27796671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
    Nagaoka T; Sogawa K; Yoshida A
    Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of natural course, intravitreal triamcinolone, and intravitreal bevacizumab for treatment of macular edema secondary to branch retinal vein occlusion.
    Kwon SI; Kim YW; Bang YW; Lee JY; Park IW
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):5-9. PubMed ID: 23237542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of serous retinal detachment in branch retinal vein occlusion and response after primary intravitreal bevacizumab injection.
    Poon YC; Chen CH; Kuo HK; Chen YJ; Wu PC; Chen YH; Lee JJ
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):319-24. PubMed ID: 23145863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1).
    Moradian S; Faghihi H; Sadeghi B; Piri N; Ahmadieh H; Soheilian M; Dehghan MH; Azarmina M; Esfahani MR
    Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):193-200. PubMed ID: 21337043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion.
    Donati S; Barosi P; Bianchi M; Al Oum M; Azzolini C
    Eur J Ophthalmol; 2012; 22(4):607-14. PubMed ID: 22101497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion.
    Hung KH; Lee SM; Lee SY; Lee FL; Yang CS
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):85-90. PubMed ID: 20148661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between optical coherence tomographic hyperreflective foci and visual outcomes after intravitreal bevacizumab for macular edema in branch retinal vein occlusion.
    Kang JW; Lee H; Chung H; Kim HC
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1413-21. PubMed ID: 24577742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Early Anatomical and Functional Responses to Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Noh D; Ryu G; Lee J; Sagong M
    Ophthalmologica; 2018; 239(4):194-204. PubMed ID: 29393235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of intravitreal bevacizumab on patients with macular edema secondary to branch retinal vein occlusion.
    Ahmadi AA; Chuo JY; Banashkevich A; Ma PE; Maberley DA
    Can J Ophthalmol; 2009 Apr; 44(2):154-9. PubMed ID: 19491948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study.
    Moschos MM; Moschos M
    Doc Ophthalmol; 2008 Mar; 116(2):147-52. PubMed ID: 18189152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.